Results 311 to 320 of about 1,630,882 (368)

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

American Journal of Psychiatry, 2010
OBJECTIVE Various classes of antidepressant medications generally induce remission of major depressive disorder in only about one-third of patients. In a previous study using mirtazapine or paroxetine alone or in combination from treatment initiation ...
P. Blier, H. Ward, P. Tremblay, Louise Laberge, C. Hébert, R. Bergeron   +5 more
semanticscholar   +1 more source

Methods for Double-Blind Peer Review and Grade Prediction of Student Software Projects

2019 42nd International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO), 2019
In software engineering courses with many students, it is often impossible for a professor to give a detailed review of the software project for each student. One solution is to give students a task to make reviews for a few projects. One review consists of a comment on a project and a score.
Irfan Prazina, Vensada Okanovic
openaire   +2 more sources

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.

American Journal of Psychiatry, 2010
OBJECTIVE The purpose of the present study was to evaluate the efficacy and tolerability of olanzapine long-acting injection for maintenance treatment of schizophrenia.
J. Kane, H. Detke, D. Naber, G. Sethuraman, D. Lin, R. Bergstrom, D. McDonnell   +6 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

American Journal of Psychiatry, 2005
OBJECTIVE There is a major unmet need for effective options in the treatment of bipolar depression. METHOD Five hundred forty-two outpatients with bipolar I (N=360) or II (N=182) disorder experiencing a major depressive episode (DSM-IV) were randomly ...
J. Calabrese, P. Keck, W. Macfadden, M. Minkwitz, T. Ketter, R. Weisler, A. Cutler, R. McCoy, E. Wilson, J. Mullen   +9 more
semanticscholar   +1 more source

[Proposed method for double-blind study of reflexotherapy phenomena].

Minerva medica, 1980
The Authors report their experience with the placebo, an essential step in the clinical study of reflexotherapy. They assert that also in this branch of medicine it is possible to carry out a "double blind" clinical experimentation by means of placebo, that is, an essential condition in order to develop a scientific assessment of both the limits and ...
Ceccherelli F, Ambrosio F, Manani G, Zanardi L, GIUSTI, PIETRO   +4 more
openaire   +2 more sources

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

Journal of Clinical Psychiatry, 2010
OBJECTIVE The aim of this study was to compare the efficacy and tolerability of quetiapine and lithium monotherapy with that of placebo for a major depressive episode in bipolar disorder.
A. Young, S. McElroy, M. Bauer, N. Philips, William Chang, B. Olausson, B. Paulsson, M. Brecher   +7 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania.

Journal of Clinical Psychiatry, 2010
BACKGROUND Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largely been unsuccessful.
M. Van Ameringen, C. Mancini, B. Patterson, M. Bennett, J. Oakman   +4 more
semanticscholar   +1 more source

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

Journal of Clinical Psychiatry, 2010
OBJECTIVE The aim of this study was to evaluate the efficacy and tolerability of quetiapine and paroxetine monotherapy for major depression in bipolar disorder. METHOD 740 patients (478 bipolar I, 262 bipolar II) with major depressive episodes (DSM-IV)
S. McElroy, R. Weisler, William Chang, B. Olausson, B. Paulsson, M. Brecher, V. Agambaram, C. Merideth, A. Nordenhem, A. Young   +9 more
semanticscholar   +1 more source

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Journal of Clinical Psychiatry, 1999
BACKGROUND We report the findings from the first large, double-blind, placebo-controlled study conducted to evaluate the efficacy and safety of risperidone in the treatment of psychotic and behavioral symptoms in institutionalized elderly patients with ...
I. Katz, D. Jeste, J. Mintzer, C. Clyde, Judy Napolitano, M. Brecher   +5 more
semanticscholar   +1 more source

Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.

Journal of Clinical Psychiatry, 2009
OBJECTIVE Lurasidone is a novel psychotropic agent with high affinity for D(2) and 5-HT(2A) receptors, as well as for receptors implicated in the enhancement of cognition and mood and the reduction of negative symptoms (5-HT(7), 5-HT(1A), and alpha(2c)).
Mitsutaka Nakamura, M. Ogasa, J. Guarino, D. Phillips, Joseph M. Severs, J. Cucchiaro, A. Loebel   +6 more
semanticscholar   +1 more source